• Registration, Cancellation policy, Scholarships
  • Auditorium Maximum UJ

Goal

To provide updated diagnostically relevant information on predominantly immunohistochemical markers, useful antibodies, optimal clones and optimal antibody panels applicable in…

Read More

Speakers

(in alphabetical order) Andrew Bellizzi (USA) Andrew M Bellizzi, M.D. is a Clinical Professor in the Department of Pathology at…

Read More

Organizing / Scientific Committee

Course Director: Janusz Ryś MD. PhD. Members: Agnieszka Adamczyk PhD.Artur Bartczak MD.Agnieszka Klimkowska PhD.Jan Klos MD.Artur Kowalik PhD.Anna Kruczak PhD.Krzysztof…

Read More

Language, Participants

Language: The language of the course is English. Participants: The target groups are consultant pathologists and pathologists in training. The…

Read More

Venue, Travel, Contact

Auditorium Maximum of the Jagiellonian UniversityKrupnicza 33, Kraków(17-19th April 2024) Travel The old city of Krakow is a tourist attraction…

Read More
Read More

Program

PDF file can be downloaded from the top menu.

  • 09.00 – 10.00

    Registration and coffee

  • 10.00 – 10.10

    Introduction – J. Ryś

  • 10.10 – 11.10

    Technology in Immunohistochemistry – S. Nielsen

  • 11.10 – 12.00

    Interpretation Pitfalls – J. Klos

  • 12.00 – 13.00

    Lunch (60’)

  • 13.00 – 14.15

    The role of Immunohistochemistry and Molecular Pathology in Diagnosing Tumors of the Lower Genital Tract – B. Davidson

  • 14.15 – 15.00

    Endometrial Carcinoma, What You Need to Know Now – A. Malpica

  • 15.00 – 15.30

    Coffee

  • 15.30 – 16.30

    Ovarian and Fallopian Tube Tumors, Soundbites – A. Malpica

  • 16.30 – 17.30

    Current challenges and practical aspects of the immunohistochemistry and molecular pathology of rare gynecological mesenchymal tumors (sarcomas). – P. Dundr

  • 08.30 – 09.15

    Histological, Immunohistochemical and Molecular Subtypes of TNBC – G. Cserni

  • 09.15 – 10.00

    HER2- High and Low Breast Cancer – T. Tot

  • 10.00 – 10.30

    Coffee (30’)

  • 10.30 – 11.15

    Histological, Immunohistochemical and Molecular Approach to Differential Diagnosis of Pulmonary Malignant Neoplasms – A. Nicholson

  • 11.15 – 12.00

    IHC based predictive biomarkers for solid tumors (novel PD-L1 applications, claudin 18 and Ceacam 5) – H-U. Schildhaus

  • 12.00 – 12.30

    Tuft Cell-like Carcinoma. The New Kid on the Block – J. Lasota

  • 12.30 – 13.30

    Lunch (60’)

  • 13.30 – 14.15

    Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology. – M. Miettinen

  • 14.15 – 15.00

    Optical Genome Mapping for comprehensive cytogenetic analysis of soft tissue and bone tumours. M. Dębiec-Rychter

  • 15.00 – 15.30

    Coffee (30’)

  • 15.30 – 16.15

    Publicly available genomic datasets – an important resource for precision oncology M. Dębiec-Rychter

  • 16.15 – 17.45

    Consultation corner (10 – 12 cases) – A. Malpica, B. Davidson, M. Miettinen

  • 08.30 – 09.15

    Cancer of unknown origin.  A. Bellizzi

  • 09.15 – 10.00

    Cancers of Unknown Primary Site: Clinical and Molecular Approach. K. Tałasiewicz

  • 10.00 – 10.30

    Coffee (30’)

  • 10.30 – 11.15

    Targeted therapies with companion diagnostics in the management of cancer patients: future perspectives. – I. Ługowska

  • 11.15 – 12.00

    Next generation molecular board for functional precision medicine. M. Karmal

  • 12.00 – 13.00

    Lunch (60’)

  • 13.00 – 13.45

    Immunohistochemical detection of predictive biomarkers for molecularly targeted therapies and immunotherapies.  J. Lasota

  • 13.45 – 14.30

    Immunohistochemistry of Head and Neck tumors. A. Bellizzi

  • 14.30 – 15.00

    Coffee (30’)

  • 15.00 – 15.30

    AI and Digital Pathology – K. Korski

  • 15.30 – 16.00

    Digital analysis of predictive factors in breast cancer – A. Kowalewski

  • 16.00 – 16.15

    Summary and conclusions – J. Ryś

  • 17th April 2024, 19.00 – 22.00

    Dinner for participants by the invitation and sponsorship of the Mayor of the City of Krakow *

  • * Declaration from the Organizers: No resources from INFARMA associated companies are involved.